New Stroke-Prevention Stent Shows Perfect 50-Patient Record

Fifty high-risk patients just walked away from a delicate artery procedure without a single stroke, heart attack, or death, and doctors are calling the results remarkable.

InspireMD's CGuard Prime stent completed its 30-day trial milestone with results that rarely appear in medical studies: 100% success. Every single patient who received the device during a procedure called TCAR came through safely, with no blood clots and completely open arteries.

TCAR stands for transcarotid artery revascularization, a procedure that clears blocked neck arteries to prevent strokes. It's already saving lives, but this new longer stent could make the treatment even safer for people whose anatomy makes surgery risky.

The trial ran across 11 medical centers, giving doctors experience with the device in real-world conditions. Researchers tracked deaths, strokes, heart attacks, and blood clots. The 30-day scorecard showed zeros across the board.

The Ripple Effect

More than 35,000 Americans undergo TCAR procedures every year, and many of them are considered high-risk because of their age or other health conditions. A device that can thread through these delicate arteries with a perfect safety record could give hope to patients who have run out of good options.

The stent uses a special mesh design that catches debris before it can travel to the brain and cause a stroke. During the procedure, doctors also use a neuroprotection system that temporarily reverses blood flow, creating a double layer of safety.

The Food and Drug Administration is currently reviewing the device, with a potential approval decision coming in the second half of 2026. If approved, it would give surgeons a new tool for one of medicine's most delicate challenges: clearing arteries near the brain without causing the very stroke they're trying to prevent.

For now, the device remains investigational in the United States. But the early results suggest that the 50 patients in this trial may be the first of many to benefit from a technology that turns a dangerous procedure into a routine one.

Medical breakthroughs often come with caveats and complications, but sometimes the data tells a simple story: fifty patients, zero problems, and thousands more who might someday benefit.